Clinical Trial Update: Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of gemcitabine, trastuzumab (Herceptin), and radiation for pancreatic cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasms

Drugs mentioned

• Gemzar (gemcitabine)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Cancer, Pancreatic Neoplasm | Phase 2 | Status: COMPLETED